# Benitec Biopharma Inc.: Form 8-K, filed Sep 28, 2023

- Company: [Benitec Biopharma Inc.](/companies/bntc.md) (CIK 1808898)
- Form: 8-K
- Filed: 2023-09-28
- Accepted by EDGAR: Sep 28, 2023, 17:19 ET
- Period: 2023-09-28
- Accession: 0001193125-23-245807
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1808898/000119312523245807/d512438d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1808898/000119312523245807/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1808898/000119312523245807/d512438d8k.htm

Filed Sep 28, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-245807. Last ingested by Listed: Nov 14, 2026, 11:28 ET. No prices; not investment advice.
